SEC Form 4 · accession 0001209191-17-038975
Arcadia Biosciences, Inc. · RKDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew T Plavan
Officer — Chief Financial Officer
Period of report
Jun 8, 2017
Accepted (ET)
Jun 9, 2017 · 6:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001469443
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.70 | Jun 8, 2017 | A | 225,000 | A | Jun 8, 2018 | Jun 8, 2027 | Common Stock | 225,000 | 225,000 | D |
Explanation of responses
- F125% of the total number of shares subject to the Option will vest on the first anniversary of the date of the award; the remaining 75% will vest in 36 equal installments, subject to the Participant's continued service.